• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Basiliximab Approval Information - Licensing Action

Proper name: Basiliximab
Tradename: Simulect
Manufacturer: Novartis Pharmaceutical Corp, East Hanover, NJ, License #1244
Indication for Use: Include the addition of a new single dose 10mg strength of drug product
Approval Date: 1/2/2003
Type of submission: Biologics license application supplement


Label (PDF)